What is the endocannabinoid system? #brain #neuroscience

🧠 Understanding the endocannabinoid system (ECS) is increasingly relevant to clinical practice, as this regulatory network modulates pain, mood, appetite, immune function, and neuroplasticity through CB1 and CB2 receptors and endogenous ligands like anandamide and 2-AG. However, translating basic ECS neuroscience into clinical guidance remains challenging because cannabis’s effects depend on cannabinoid ratios (THC versus CBD), individual genetic variation in receptor expression, route of administration, and dose—factors that complicate straightforward therapeutic recommendations. Clinicians should recognize that while preclinical evidence supports potential roles for cannabinoid modulation in chronic pain, epilepsy, and certain psychiatric conditions, the clinical evidence base remains sparse and heterogeneous, with limited long-term safety data especially in developing brains and during pregnancy. When patients inquire about cannabis or request it for symptom management